HILLHOUSE INVESTMENT MANAGEMENT, LTD.
10% Owner
FundSelling only
- 2026
- Feb 3, 2026
- 1
Other insiders active in the same sector
No other insider has filed at HILLHOUSE INVESTMENT MANAGEMENT, LTD.'s companies, so these are insiders reporting open-market trades at other companies in the same sector.
- GTCR INVESTMENT XI LLC - $639.50M in SHC purchases and sales in the last 12 months
- Keith A. Meister - $591.13M in ILMN purchases and sales in the last 12 months
- Ronda E. Stryker - $580.89M in SYK purchases and sales in the last 12 months
- Mozart Aggregator II LP - $579.20M in MDLN purchases and sales in the last 12 months
- TC Group VII S1, L.L.C. - $554.95M in MDLN purchases and sales in the last 12 months
- BERKSHIRE HATHAWAY INC - $473.67M in DVA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is HILLHOUSE INVESTMENT MANAGEMENT, LTD.?
HILLHOUSE INVESTMENT MANAGEMENT, LTD. is an investment firm, tracked as 10% Owner of ArriVent BioPharma, Inc. (AVBP). InsiderAlpha holds 1 primary Form 4 filing for it, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did HILLHOUSE INVESTMENT MANAGEMENT, LTD. last file a Form 4?
The only primary Form 4 on record is dated 3 February 2026.
Has HILLHOUSE INVESTMENT MANAGEMENT, LTD. been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($12.98M) across all tracked filings.
